Replies to post #99526 on Value Microcaps Motherboard

[cliffvb]

LTUS - Company also spent $900,000 in Q4 and $2.4 mil on R&D for all of last year which is over 6 times what they spent in '06.
Sounds like the payoff may be coming soon with numerous new products. These will be added to their 4 existing branded products. This is from the new 10K:

Lotus East has a product pipeline containing approximately seven products in different
dosage forms which are ready for commercialization in China for the treatment of
diseases. Lotus East expects to receive Chinese SFDA approvals on those products
in the near future. Lotus East intends to commercialize or license these drugs
during 2008 and 2009. In 2007, Lotus East resumed its new drug research and
development effort and started five new research and development projects and
those projects are in different development stages. Major projects currently
being undertaken at these centers focus on the following:

DRUG NAME TARGET TREATMENT STATUS (A)
---------------------------------------------------------------------------------------------------------------------------------
Calcium Dibutyryl Adensine used to cure angina and acute myocardial infarction Pending final SFDA approval
Monophosphate for Injection
---------------------------------------------------------------------------------------------------------------------------------
Rabeprazole Sodium raw material and used for curing gastric ulcer, duodenal ulcer, Pending final SFDA approval
Rabeprazole Sodium Enteric-coated stomach ulcer, reflux esophagitis, Zollinger-Ellison
symptom complex and gastrinoma
---------------------------------------------------------------------------------------------------------------------------------
Compound Allantoin Dispersible Tablets used for curing gastrelcosis, duodenal bulbar ulcer Pending final SFDA approval
and chronic gastritis
---------------------------------------------------------------------------------------------------------------------------------
Gatifloxacin Lactate for Injection used for curing acute nasosinusitis, chronic Pending final SFDA approval
bronchitis, pneumonia, gonorrhea, and rectum
---------------------------------------------------------------------------------------------------------------------------------
Sodium Aescinate for Injection use for curing hydrocephalus, swelling caused by Pending final SFDA approval
wounds or surgery operation and for venous return
disorder.
---------------------------------------------------------------------------------------------------------------------------------
Candesartan Pills used for curing essential hypertension Pending final SFDA approval
---------------------------------------------------------------------------------------------------------------------------------

10


--------------------------------------------------------------------------------



DRUG NAME TARGET TREATMENT STATUS (A)
---------------------------------------------------------------------------------------------------------------------------------
Nicergoline Pills used for the curing feeling dullness, impaired Pending final SFDA approval
concentration, memory deterioration, gloom and
restlessness caused by cerebral infarction sequela
---------------------------------------------------------------------------------------------------------------------------------
Isosorbide Mononitrate-Sustained used for preventing angina (chest pain) caused by Pending SFDA approval
Release Tablets heart disease.